{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:40:18Z","timestamp":1763116818074},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1001\/amajethics.2021.537","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T11:14:40Z","timestamp":1628248480000},"page":"E537-541","source":"Crossref","is-referenced-by-count":3,"title":["Questioning Biomedicine's Privileging of Disease and Measurability"],"prefix":"10.1001","volume":"23","member":"10","published-online":{"date-parts":[[2021,7,1]]},"container-title":["AMA Journal of Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/questioning-biomedicines-privileging-disease-and-measurability\/2021-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T15:58:50Z","timestamp":1683734330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/questioning-biomedicines-privileging-disease-and-measurability\/2021-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":0,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]}},"alternative-id":["10.1001\/amajethics.2021.537"],"URL":"https:\/\/doi.org\/10.1001\/amajethics.2021.537","relation":{},"ISSN":["2376-6980"],"issn-type":[{"value":"2376-6980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}